|
|
||||||||
Ann Thorac Surg 2001;71:2081
© 2001 The Society of Thoracic Surgeons
a 3108 Queeny Tower, Washington University School of Medicine, One Barnes-Jewish Hospital Plaza, St. Louis, MO 63110, USA
e-mail: meyersb@msnotes.wustl.edu
To the Editor
We read with interest the prospective, randomized trial by Geddes and associates [1]. We agree with the conclusions: lung volume reduction surgery (LVRS) can improve first second expired volume (FEV1), walking distance, and quality of life in selected emphysema patients who have exhausted nonsurgical alternatives. While the measured benefit from LVRS was less than that reported from many centers, outcomes were likely influenced by the authors inclusion of patients with diffuse emphysema and poor exercise capabilities. Geddes and associates
This article has been cited by other articles:
![]() |
J. D. Cooper Paying the piper: the NETT strikes a sour note Ann. Thorac. Surg., August 1, 2001; 72(2): 330 - 333. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |